178 related articles for article (PubMed ID: 38221889)
1. Matched analysis of detailed peripheral blood and tumor immune microenvironment profiles in bladder cancer.
Chen JQ; Salas LA; Wiencke JK; Koestler DC; Molinaro AM; Andrew AS; Seigne JD; Karagas MR; Kelsey KT; Christensen BC
Epigenomics; 2024 Jan; 16(1):41-56. PubMed ID: 38221889
[TBL] [Abstract][Full Text] [Related]
2. Genome-Scale Methylation Analysis Identifies Immune Profiles and Age Acceleration Associations with Bladder Cancer Outcomes.
Chen JQ; Salas LA; Wiencke JK; Koestler DC; Molinaro AM; Andrew AS; Seigne JD; Karagas MR; Kelsey KT; Christensen BC
Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1328-1337. PubMed ID: 37527159
[TBL] [Abstract][Full Text] [Related]
3. Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer.
Li F; Guo H; Wang Y; Liu B; Zhou H
Int Immunopharmacol; 2020 Aug; 85():106641. PubMed ID: 32470882
[TBL] [Abstract][Full Text] [Related]
4. m
Sun M; Xie M; Zhang T; Wang Y; Huang W; Xia L
Front Immunol; 2021; 12():739768. PubMed ID: 34616403
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
Front Immunol; 2022; 13():976107. PubMed ID: 36091006
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analyses of a tumor-infiltrating lymphocytes-related gene signature regarding the prognosis and immunologic features for immunotherapy in bladder cancer on the basis of WGCNA.
He Z; Gu J; Luan T; Li H; Li C; Chen Z; Luo E; Wang J; Huang Y; Ding M
Front Immunol; 2022; 13():973974. PubMed ID: 36211333
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis.
Koll FJ; Banek S; Kluth L; Köllermann J; Bankov K; Chun FK; Wild PJ; Weigert A; Reis H
J Transl Med; 2023 Feb; 21(1):124. PubMed ID: 36793050
[TBL] [Abstract][Full Text] [Related]
8. Profiles of Immune Infiltration in Bladder Cancer and its Clinical Significance: an Integrative Genomic Analysis.
Wu Z; Zhu K; Liu Q; Liu Y; Chen L; Cui J; Guo H; Zhou N; Zhu Y; Li Y; Shi B
Int J Med Sci; 2020; 17(6):762-772. PubMed ID: 32218698
[TBL] [Abstract][Full Text] [Related]
9. m
Chong W; Shang L; Liu J; Fang Z; Du F; Wu H; Liu Y; Wang Z; Chen Y; Jia S; Chen L; Li L; Chen H
Theranostics; 2021; 11(5):2201-2217. PubMed ID: 33500720
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment.
Zheng X; Ma Y; Bai Y; Huang T; Lv X; Deng J; Wang Z; Lian W; Tong Y; Zhang X; Yue M; Zhang Y; Li L; Peng M
Front Immunol; 2022; 13():984480. PubMed ID: 36389763
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer.
Marsit CJ; Koestler DC; Christensen BC; Karagas MR; Houseman EA; Kelsey KT
J Clin Oncol; 2011 Mar; 29(9):1133-9. PubMed ID: 21343564
[TBL] [Abstract][Full Text] [Related]
12. Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients.
Starzer AM; Berghoff AS; Hamacher R; Tomasich E; Feldmann K; Hatziioannou T; Traint S; Lamm W; Noebauer-Huhmann IM; Furtner J; Müllauer L; Amann G; Bauer S; Schildhaus HU; Preusser M; Heller G; Brodowicz T
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33762319
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Tumor Microenvironment Characteristics in Bladder Cancer: Implications for Immune Checkpoint Inhibitor Therapy.
Chen X; Chen H; He D; Cheng Y; Zhu Y; Xiao M; Lan H; Wang Z; Cao K
Front Immunol; 2021; 12():672158. PubMed ID: 33936117
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B
Front Immunol; 2022; 13():914577. PubMed ID: 35757739
[TBL] [Abstract][Full Text] [Related]
15. Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer.
Masuda T; Tanaka N; Takamatsu K; Hakozaki K; Takahashi R; Anno T; Kufukihara R; Shojo K; Mikami S; Shinojima T; Kakimi K; Tsunoda T; Aimono E; Nishihara H; Mizuno R; Oya M
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35314433
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of tumor-infiltrating lymphocyte-related prognosis signature for predicting prognosis and immunotherapeutic response in bladder cancer.
Li C; Xie W
BMC Bioinformatics; 2023 Mar; 24(1):118. PubMed ID: 36973645
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
Yang H; Zhao L; Zhang Y; Li FF
Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
19. Characterization of m6A methylation modifications and tumor microenvironment infiltration in thyroid cancer.
Ji FH; Yang Z; Sun C; Lowe S; Qiu XG
Clin Transl Oncol; 2023 Jan; 25(1):269-282. PubMed ID: 36163443
[TBL] [Abstract][Full Text] [Related]
20. Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes.
Chen JQ; Salas LA; Wiencke JK; Koestler DC; Molinaro AM; Andrew AS; Seigne JD; Karagas MR; Kelsey KT; Christensen BC
Clin Epigenetics; 2022 Jan; 14(1):14. PubMed ID: 35063012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]